Panaxia Labs Israel Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was ILS 17.615 million compared to ILS 14.777 million a year ago. Operating income was ILS 3.717 million compared to operating loss of ILS 8.607 million a year ago. Net income was ILS 3.623 million compared to net loss of ILS 8.737 million a year ago. Basic earnings per share from continuing operations was ILS 0.02 compared to basic loss per share from continuing operations of ILS 0.08 a year ago. For the half year, sales was ILS 37.285 million compared to ILS 26.945 million a year ago. Operating loss was ILS 4.336 million compared to ILS 17.887 million a year ago. Net loss was ILS 4.656 million compared to ILS 18.148 million a year ago. Basic loss per share from continuing operations was ILS 0.04 compared to ILS 0.17 a year ago.